Our investments target everyday diseases that impact people worldwide.

We believe AI will accelerate the democratization of advances in healthcare, enabling us to extend tools from the US to the farthest corners of the globe.

Many diseases are overlooked, patched up with inadequate "band-aid” solutions.

We believe this is inadequate and strive to partner with developing disease modifying cures.

Care transcends the confines of hospital walls. We believe TechBio has the potential to revolutionize care delivery, reaching patients wherever they are. TechBio innovates at every level, improving hospital and provider systems, providing superior tools for care delivery and decision-making, and developing faster and more effective prescription drugs.

True transformation arises from a holistic approach, not isolated within a single realm. En masse tools alone won't achieve superior outcomes; personalization is the key to addressing healthcare on a grand scale. Data remains the answer in solving this intricate healthcare puzzle.

Great founders come in different forms. We embrace diversity in our portfolio with over 60% of founders identifying as PoC, LGBT, or women.

We invest in visionary thinkers who are equally as compassionate to those around them.